Global Continuous Subcutaneous Insulin Infusion Devices Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Continuous Subcutaneous Insulin Infusion Devices is a medical device used for the administration of insulin in the treatment of diabetes mellitus
LPI (LP Information)' newest research report, the “Continuous Subcutaneous Insulin Infusion Devices Industry Forecast” looks at past sales and reviews total world Continuous Subcutaneous Insulin Infusion Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Continuous Subcutaneous Insulin Infusion Devices sales for 2023 through 2029. With Continuous Subcutaneous Insulin Infusion Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Continuous Subcutaneous Insulin Infusion Devices industry.
This Insight Report provides a comprehensive analysis of the global Continuous Subcutaneous Insulin Infusion Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Continuous Subcutaneous Insulin Infusion Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Continuous Subcutaneous Insulin Infusion Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Continuous Subcutaneous Insulin Infusion Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Continuous Subcutaneous Insulin Infusion Devices.
The global Continuous Subcutaneous Insulin Infusion Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Continuous Subcutaneous Insulin Infusion Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Continuous Subcutaneous Insulin Infusion Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Continuous Subcutaneous Insulin Infusion Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Continuous Subcutaneous Insulin Infusion Devices players cover Medtronic, Roche, Insulet Corp, Tandem Diabetes care, Valeritas, SOOIL and Microport, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Continuous Subcutaneous Insulin Infusion Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Continuous Subcutaneous Insulin Infusion Devices market?
What factors are driving Continuous Subcutaneous Insulin Infusion Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Continuous Subcutaneous Insulin Infusion Devices market opportunities vary by end market size?
How does Continuous Subcutaneous Insulin Infusion Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Continuous Subcutaneous Insulin Infusion Devices is a medical device used for the administration of insulin in the treatment of diabetes mellitus
LPI (LP Information)' newest research report, the “Continuous Subcutaneous Insulin Infusion Devices Industry Forecast” looks at past sales and reviews total world Continuous Subcutaneous Insulin Infusion Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Continuous Subcutaneous Insulin Infusion Devices sales for 2023 through 2029. With Continuous Subcutaneous Insulin Infusion Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Continuous Subcutaneous Insulin Infusion Devices industry.
This Insight Report provides a comprehensive analysis of the global Continuous Subcutaneous Insulin Infusion Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Continuous Subcutaneous Insulin Infusion Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Continuous Subcutaneous Insulin Infusion Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Continuous Subcutaneous Insulin Infusion Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Continuous Subcutaneous Insulin Infusion Devices.
The global Continuous Subcutaneous Insulin Infusion Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Continuous Subcutaneous Insulin Infusion Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Continuous Subcutaneous Insulin Infusion Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Continuous Subcutaneous Insulin Infusion Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Continuous Subcutaneous Insulin Infusion Devices players cover Medtronic, Roche, Insulet Corp, Tandem Diabetes care, Valeritas, SOOIL and Microport, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Continuous Subcutaneous Insulin Infusion Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Normal Pump
- Patch Pump
- Type I Diabetes
- Type II Diabetes
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medtronic
- Roche
- Insulet Corp
- Tandem Diabetes care
- Valeritas
- SOOIL
- Microport
What is the 10-year outlook for the global Continuous Subcutaneous Insulin Infusion Devices market?
What factors are driving Continuous Subcutaneous Insulin Infusion Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Continuous Subcutaneous Insulin Infusion Devices market opportunities vary by end market size?
How does Continuous Subcutaneous Insulin Infusion Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Continuous Subcutaneous Insulin Infusion Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Continuous Subcutaneous Insulin Infusion Devices by Country/Region, 2018, 2022 & 2029
2.2 Continuous Subcutaneous Insulin Infusion Devices Segment by Type
2.2.1 Normal Pump
2.2.2 Patch Pump
2.3 Continuous Subcutaneous Insulin Infusion Devices Sales by Type
2.3.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2018-2023)
2.3.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Type (2018-2023)
2.4 Continuous Subcutaneous Insulin Infusion Devices Segment by Application
2.4.1 Type I Diabetes
2.4.2 Type II Diabetes
2.5 Continuous Subcutaneous Insulin Infusion Devices Sales by Application
2.5.1 Global Continuous Subcutaneous Insulin Infusion Devices Sale Market Share by Application (2018-2023)
2.5.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Application (2018-2023)
3 GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION DEVICES BY COMPANY
3.1 Global Continuous Subcutaneous Insulin Infusion Devices Breakdown Data by Company
3.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Annual Sales by Company (2018-2023)
3.1.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Company (2018-2023)
3.2 Global Continuous Subcutaneous Insulin Infusion Devices Annual Revenue by Company (2018-2023)
3.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Company (2018-2023)
3.2.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Company (2018-2023)
3.3 Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Company
3.4 Key Manufacturers Continuous Subcutaneous Insulin Infusion Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Continuous Subcutaneous Insulin Infusion Devices Product Location Distribution
3.4.2 Players Continuous Subcutaneous Insulin Infusion Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION DEVICES BY GEOGRAPHIC REGION
4.1 World Historic Continuous Subcutaneous Insulin Infusion Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Continuous Subcutaneous Insulin Infusion Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Continuous Subcutaneous Insulin Infusion Devices Market Size by Country/Region (2018-2023)
4.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global Continuous Subcutaneous Insulin Infusion Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Continuous Subcutaneous Insulin Infusion Devices Sales Growth
4.4 APAC Continuous Subcutaneous Insulin Infusion Devices Sales Growth
4.5 Europe Continuous Subcutaneous Insulin Infusion Devices Sales Growth
4.6 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Growth
5 AMERICAS
5.1 Americas Continuous Subcutaneous Insulin Infusion Devices Sales by Country
5.1.1 Americas Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2023)
5.1.2 Americas Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2023)
5.2 Americas Continuous Subcutaneous Insulin Infusion Devices Sales by Type
5.3 Americas Continuous Subcutaneous Insulin Infusion Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Continuous Subcutaneous Insulin Infusion Devices Sales by Region
6.1.1 APAC Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2018-2023)
6.1.2 APAC Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2018-2023)
6.2 APAC Continuous Subcutaneous Insulin Infusion Devices Sales by Type
6.3 APAC Continuous Subcutaneous Insulin Infusion Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Continuous Subcutaneous Insulin Infusion Devices by Country
7.1.1 Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2023)
7.1.2 Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2023)
7.2 Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Type
7.3 Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices by Country
8.1.1 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Type
8.3 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Continuous Subcutaneous Insulin Infusion Devices
10.3 Manufacturing Process Analysis of Continuous Subcutaneous Insulin Infusion Devices
10.4 Industry Chain Structure of Continuous Subcutaneous Insulin Infusion Devices
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Continuous Subcutaneous Insulin Infusion Devices Distributors
11.3 Continuous Subcutaneous Insulin Infusion Devices Customer
12 WORLD FORECAST REVIEW FOR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION DEVICES BY GEOGRAPHIC REGION
12.1 Global Continuous Subcutaneous Insulin Infusion Devices Market Size Forecast by Region
12.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Forecast by Region (2024-2029)
12.1.2 Global Continuous Subcutaneous Insulin Infusion Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Continuous Subcutaneous Insulin Infusion Devices Forecast by Type
12.7 Global Continuous Subcutaneous Insulin Infusion Devices Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
13.1.3 Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
13.2.3 Roche Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Insulet Corp
13.3.1 Insulet Corp Company Information
13.3.2 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
13.3.3 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Insulet Corp Main Business Overview
13.3.5 Insulet Corp Latest Developments
13.4 Tandem Diabetes care
13.4.1 Tandem Diabetes care Company Information
13.4.2 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
13.4.3 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Tandem Diabetes care Main Business Overview
13.4.5 Tandem Diabetes care Latest Developments
13.5 Valeritas
13.5.1 Valeritas Company Information
13.5.2 Valeritas Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
13.5.3 Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Valeritas Main Business Overview
13.5.5 Valeritas Latest Developments
13.6 SOOIL
13.6.1 SOOIL Company Information
13.6.2 SOOIL Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
13.6.3 SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 SOOIL Main Business Overview
13.6.5 SOOIL Latest Developments
13.7 Microport
13.7.1 Microport Company Information
13.7.2 Microport Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
13.7.3 Microport Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Microport Main Business Overview
13.7.5 Microport Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Continuous Subcutaneous Insulin Infusion Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Continuous Subcutaneous Insulin Infusion Devices by Country/Region, 2018, 2022 & 2029
2.2 Continuous Subcutaneous Insulin Infusion Devices Segment by Type
2.2.1 Normal Pump
2.2.2 Patch Pump
2.3 Continuous Subcutaneous Insulin Infusion Devices Sales by Type
2.3.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2018-2023)
2.3.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Type (2018-2023)
2.4 Continuous Subcutaneous Insulin Infusion Devices Segment by Application
2.4.1 Type I Diabetes
2.4.2 Type II Diabetes
2.5 Continuous Subcutaneous Insulin Infusion Devices Sales by Application
2.5.1 Global Continuous Subcutaneous Insulin Infusion Devices Sale Market Share by Application (2018-2023)
2.5.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Application (2018-2023)
3 GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION DEVICES BY COMPANY
3.1 Global Continuous Subcutaneous Insulin Infusion Devices Breakdown Data by Company
3.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Annual Sales by Company (2018-2023)
3.1.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Company (2018-2023)
3.2 Global Continuous Subcutaneous Insulin Infusion Devices Annual Revenue by Company (2018-2023)
3.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Company (2018-2023)
3.2.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Company (2018-2023)
3.3 Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Company
3.4 Key Manufacturers Continuous Subcutaneous Insulin Infusion Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Continuous Subcutaneous Insulin Infusion Devices Product Location Distribution
3.4.2 Players Continuous Subcutaneous Insulin Infusion Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION DEVICES BY GEOGRAPHIC REGION
4.1 World Historic Continuous Subcutaneous Insulin Infusion Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Continuous Subcutaneous Insulin Infusion Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Continuous Subcutaneous Insulin Infusion Devices Market Size by Country/Region (2018-2023)
4.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global Continuous Subcutaneous Insulin Infusion Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Continuous Subcutaneous Insulin Infusion Devices Sales Growth
4.4 APAC Continuous Subcutaneous Insulin Infusion Devices Sales Growth
4.5 Europe Continuous Subcutaneous Insulin Infusion Devices Sales Growth
4.6 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Growth
5 AMERICAS
5.1 Americas Continuous Subcutaneous Insulin Infusion Devices Sales by Country
5.1.1 Americas Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2023)
5.1.2 Americas Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2023)
5.2 Americas Continuous Subcutaneous Insulin Infusion Devices Sales by Type
5.3 Americas Continuous Subcutaneous Insulin Infusion Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Continuous Subcutaneous Insulin Infusion Devices Sales by Region
6.1.1 APAC Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2018-2023)
6.1.2 APAC Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2018-2023)
6.2 APAC Continuous Subcutaneous Insulin Infusion Devices Sales by Type
6.3 APAC Continuous Subcutaneous Insulin Infusion Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Continuous Subcutaneous Insulin Infusion Devices by Country
7.1.1 Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2023)
7.1.2 Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2023)
7.2 Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Type
7.3 Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices by Country
8.1.1 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Type
8.3 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Continuous Subcutaneous Insulin Infusion Devices
10.3 Manufacturing Process Analysis of Continuous Subcutaneous Insulin Infusion Devices
10.4 Industry Chain Structure of Continuous Subcutaneous Insulin Infusion Devices
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Continuous Subcutaneous Insulin Infusion Devices Distributors
11.3 Continuous Subcutaneous Insulin Infusion Devices Customer
12 WORLD FORECAST REVIEW FOR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION DEVICES BY GEOGRAPHIC REGION
12.1 Global Continuous Subcutaneous Insulin Infusion Devices Market Size Forecast by Region
12.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Forecast by Region (2024-2029)
12.1.2 Global Continuous Subcutaneous Insulin Infusion Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Continuous Subcutaneous Insulin Infusion Devices Forecast by Type
12.7 Global Continuous Subcutaneous Insulin Infusion Devices Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
13.1.3 Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
13.2.3 Roche Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Insulet Corp
13.3.1 Insulet Corp Company Information
13.3.2 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
13.3.3 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Insulet Corp Main Business Overview
13.3.5 Insulet Corp Latest Developments
13.4 Tandem Diabetes care
13.4.1 Tandem Diabetes care Company Information
13.4.2 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
13.4.3 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Tandem Diabetes care Main Business Overview
13.4.5 Tandem Diabetes care Latest Developments
13.5 Valeritas
13.5.1 Valeritas Company Information
13.5.2 Valeritas Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
13.5.3 Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Valeritas Main Business Overview
13.5.5 Valeritas Latest Developments
13.6 SOOIL
13.6.1 SOOIL Company Information
13.6.2 SOOIL Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
13.6.3 SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 SOOIL Main Business Overview
13.6.5 SOOIL Latest Developments
13.7 Microport
13.7.1 Microport Company Information
13.7.2 Microport Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
13.7.3 Microport Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Microport Main Business Overview
13.7.5 Microport Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Continuous Subcutaneous Insulin Infusion Devices Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Continuous Subcutaneous Insulin Infusion Devices Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Normal Pump
Table 4. Major Players of Patch Pump
Table 5. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2018-2023) & (K Units)
Table 6. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2018-2023)
Table 7. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Type (2018-2023) & ($ million)
Table 8. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Type (2018-2023)
Table 9. Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2018-2023) & (K Units)
Table 11. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2018-2023)
Table 12. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Application (2018-2023)
Table 13. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Application (2018-2023)
Table 14. Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Company (2018-2023) & (K Units)
Table 16. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Company (2018-2023)
Table 17. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Company (2018-2023)
Table 19. Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Continuous Subcutaneous Insulin Infusion Devices Producing Area Distribution and Sales Area
Table 21. Players Continuous Subcutaneous Insulin Infusion Devices Products Offered
Table 22. Continuous Subcutaneous Insulin Infusion Devices Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share Geographic Region (2018-2023)
Table 27. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country/Region (2018-2023)
Table 31. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2023) & (K Units)
Table 34. Americas Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2018-2023)
Table 35. Americas Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2018-2023)
Table 37. Americas Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2018-2023) & (K Units)
Table 38. Americas Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2018-2023) & (K Units)
Table 39. APAC Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2018-2023) & (K Units)
Table 40. APAC Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region (2018-2023)
Table 41. APAC Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Region (2018-2023)
Table 43. APAC Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2018-2023) & (K Units)
Table 44. APAC Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2018-2023) & (K Units)
Table 45. Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2023) & (K Units)
Table 46. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2018-2023)
Table 47. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2018-2023)
Table 49. Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2018-2023) & (K Units)
Table 50. Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Continuous Subcutaneous Insulin Infusion Devices
Table 58. Key Market Challenges & Risks of Continuous Subcutaneous Insulin Infusion Devices
Table 59. Key Industry Trends of Continuous Subcutaneous Insulin Infusion Devices
Table 60. Continuous Subcutaneous Insulin Infusion Devices Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Continuous Subcutaneous Insulin Infusion Devices Distributors List
Table 63. Continuous Subcutaneous Insulin Infusion Devices Customer List
Table 64. Global Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Medtronic Basic Information, Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 79. Medtronic Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
Table 80. Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Medtronic Main Business
Table 82. Medtronic Latest Developments
Table 83. Roche Basic Information, Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 84. Roche Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
Table 85. Roche Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Roche Main Business
Table 87. Roche Latest Developments
Table 88. Insulet Corp Basic Information, Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 89. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
Table 90. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Insulet Corp Main Business
Table 92. Insulet Corp Latest Developments
Table 93. Tandem Diabetes care Basic Information, Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 94. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
Table 95. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Tandem Diabetes care Main Business
Table 97. Tandem Diabetes care Latest Developments
Table 98. Valeritas Basic Information, Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 99. Valeritas Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
Table 100. Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Valeritas Main Business
Table 102. Valeritas Latest Developments
Table 103. SOOIL Basic Information, Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 104. SOOIL Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
Table 105. SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. SOOIL Main Business
Table 107. SOOIL Latest Developments
Table 108. Microport Basic Information, Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 109. Microport Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
Table 110. Microport Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Microport Main Business
Table 112. Microport Latest Developments
Table 1. Continuous Subcutaneous Insulin Infusion Devices Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Continuous Subcutaneous Insulin Infusion Devices Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Normal Pump
Table 4. Major Players of Patch Pump
Table 5. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2018-2023) & (K Units)
Table 6. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2018-2023)
Table 7. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Type (2018-2023) & ($ million)
Table 8. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Type (2018-2023)
Table 9. Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2018-2023) & (K Units)
Table 11. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2018-2023)
Table 12. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Application (2018-2023)
Table 13. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Application (2018-2023)
Table 14. Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Company (2018-2023) & (K Units)
Table 16. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Company (2018-2023)
Table 17. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Company (2018-2023)
Table 19. Global Continuous Subcutaneous Insulin Infusion Devices Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Continuous Subcutaneous Insulin Infusion Devices Producing Area Distribution and Sales Area
Table 21. Players Continuous Subcutaneous Insulin Infusion Devices Products Offered
Table 22. Continuous Subcutaneous Insulin Infusion Devices Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share Geographic Region (2018-2023)
Table 27. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country/Region (2018-2023)
Table 31. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2023) & (K Units)
Table 34. Americas Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2018-2023)
Table 35. Americas Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2018-2023)
Table 37. Americas Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2018-2023) & (K Units)
Table 38. Americas Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2018-2023) & (K Units)
Table 39. APAC Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2018-2023) & (K Units)
Table 40. APAC Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region (2018-2023)
Table 41. APAC Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Region (2018-2023)
Table 43. APAC Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2018-2023) & (K Units)
Table 44. APAC Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2018-2023) & (K Units)
Table 45. Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2023) & (K Units)
Table 46. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2018-2023)
Table 47. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2018-2023)
Table 49. Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2018-2023) & (K Units)
Table 50. Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Continuous Subcutaneous Insulin Infusion Devices
Table 58. Key Market Challenges & Risks of Continuous Subcutaneous Insulin Infusion Devices
Table 59. Key Industry Trends of Continuous Subcutaneous Insulin Infusion Devices
Table 60. Continuous Subcutaneous Insulin Infusion Devices Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Continuous Subcutaneous Insulin Infusion Devices Distributors List
Table 63. Continuous Subcutaneous Insulin Infusion Devices Customer List
Table 64. Global Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Medtronic Basic Information, Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 79. Medtronic Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
Table 80. Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Medtronic Main Business
Table 82. Medtronic Latest Developments
Table 83. Roche Basic Information, Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 84. Roche Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
Table 85. Roche Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Roche Main Business
Table 87. Roche Latest Developments
Table 88. Insulet Corp Basic Information, Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 89. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
Table 90. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Insulet Corp Main Business
Table 92. Insulet Corp Latest Developments
Table 93. Tandem Diabetes care Basic Information, Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 94. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
Table 95. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Tandem Diabetes care Main Business
Table 97. Tandem Diabetes care Latest Developments
Table 98. Valeritas Basic Information, Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 99. Valeritas Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
Table 100. Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Valeritas Main Business
Table 102. Valeritas Latest Developments
Table 103. SOOIL Basic Information, Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 104. SOOIL Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
Table 105. SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. SOOIL Main Business
Table 107. SOOIL Latest Developments
Table 108. Microport Basic Information, Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base, Sales Area and Its Competitors
Table 109. Microport Continuous Subcutaneous Insulin Infusion Devices Product Portfolios and Specifications
Table 110. Microport Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Microport Main Business
Table 112. Microport Latest Developments
LIST OF FIGURES
Figure 1. Picture of Continuous Subcutaneous Insulin Infusion Devices
Figure 2. Continuous Subcutaneous Insulin Infusion Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Continuous Subcutaneous Insulin Infusion Devices Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Normal Pump
Figure 10. Product Picture of Patch Pump
Figure 11. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type in 2022
Figure 12. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Type (2018-2023)
Figure 13. Continuous Subcutaneous Insulin Infusion Devices Consumed in Type I Diabetes
Figure 14. Global Continuous Subcutaneous Insulin Infusion Devices Market: Type I Diabetes (2018-2023) & (K Units)
Figure 15. Continuous Subcutaneous Insulin Infusion Devices Consumed in Type II Diabetes
Figure 16. Global Continuous Subcutaneous Insulin Infusion Devices Market: Type II Diabetes (2018-2023) & (K Units)
Figure 17. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2022)
Figure 18. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Application in 2022
Figure 19. Continuous Subcutaneous Insulin Infusion Devices Sales Market by Company in 2022 (K Units)
Figure 20. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Company in 2022
Figure 21. Continuous Subcutaneous Insulin Infusion Devices Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Company in 2022
Figure 23. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Continuous Subcutaneous Insulin Infusion Devices Sales 2018-2023 (K Units)
Figure 26. Americas Continuous Subcutaneous Insulin Infusion Devices Revenue 2018-2023 ($ Millions)
Figure 27. APAC Continuous Subcutaneous Insulin Infusion Devices Sales 2018-2023 (K Units)
Figure 28. APAC Continuous Subcutaneous Insulin Infusion Devices Revenue 2018-2023 ($ Millions)
Figure 29. Europe Continuous Subcutaneous Insulin Infusion Devices Sales 2018-2023 (K Units)
Figure 30. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue 2018-2023 ($ Millions)
Figure 33. Americas Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country in 2022
Figure 34. Americas Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country in 2022
Figure 35. Americas Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2018-2023)
Figure 36. Americas Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2018-2023)
Figure 37. United States Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region in 2022
Figure 42. APAC Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Regions in 2022
Figure 43. APAC Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2018-2023)
Figure 44. APAC Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2018-2023)
Figure 45. China Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country in 2022
Figure 53. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country in 2022
Figure 54. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2018-2023)
Figure 55. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2018-2023)
Figure 56. Germany Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2018-2023)
Figure 65. Egypt Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Continuous Subcutaneous Insulin Infusion Devices in 2022
Figure 71. Manufacturing Process Analysis of Continuous Subcutaneous Insulin Infusion Devices
Figure 72. Industry Chain Structure of Continuous Subcutaneous Insulin Infusion Devices
Figure 73. Channels of Distribution
Figure 74. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Forecast by Region (2024-2029)
Figure 75. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Continuous Subcutaneous Insulin Infusion Devices
Figure 2. Continuous Subcutaneous Insulin Infusion Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Continuous Subcutaneous Insulin Infusion Devices Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Normal Pump
Figure 10. Product Picture of Patch Pump
Figure 11. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type in 2022
Figure 12. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Type (2018-2023)
Figure 13. Continuous Subcutaneous Insulin Infusion Devices Consumed in Type I Diabetes
Figure 14. Global Continuous Subcutaneous Insulin Infusion Devices Market: Type I Diabetes (2018-2023) & (K Units)
Figure 15. Continuous Subcutaneous Insulin Infusion Devices Consumed in Type II Diabetes
Figure 16. Global Continuous Subcutaneous Insulin Infusion Devices Market: Type II Diabetes (2018-2023) & (K Units)
Figure 17. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2022)
Figure 18. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Application in 2022
Figure 19. Continuous Subcutaneous Insulin Infusion Devices Sales Market by Company in 2022 (K Units)
Figure 20. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Company in 2022
Figure 21. Continuous Subcutaneous Insulin Infusion Devices Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Company in 2022
Figure 23. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Continuous Subcutaneous Insulin Infusion Devices Sales 2018-2023 (K Units)
Figure 26. Americas Continuous Subcutaneous Insulin Infusion Devices Revenue 2018-2023 ($ Millions)
Figure 27. APAC Continuous Subcutaneous Insulin Infusion Devices Sales 2018-2023 (K Units)
Figure 28. APAC Continuous Subcutaneous Insulin Infusion Devices Revenue 2018-2023 ($ Millions)
Figure 29. Europe Continuous Subcutaneous Insulin Infusion Devices Sales 2018-2023 (K Units)
Figure 30. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue 2018-2023 ($ Millions)
Figure 33. Americas Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country in 2022
Figure 34. Americas Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country in 2022
Figure 35. Americas Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2018-2023)
Figure 36. Americas Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2018-2023)
Figure 37. United States Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region in 2022
Figure 42. APAC Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Regions in 2022
Figure 43. APAC Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2018-2023)
Figure 44. APAC Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2018-2023)
Figure 45. China Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country in 2022
Figure 53. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country in 2022
Figure 54. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2018-2023)
Figure 55. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2018-2023)
Figure 56. Germany Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2018-2023)
Figure 65. Egypt Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Continuous Subcutaneous Insulin Infusion Devices Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Continuous Subcutaneous Insulin Infusion Devices in 2022
Figure 71. Manufacturing Process Analysis of Continuous Subcutaneous Insulin Infusion Devices
Figure 72. Industry Chain Structure of Continuous Subcutaneous Insulin Infusion Devices
Figure 73. Channels of Distribution
Figure 74. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Forecast by Region (2024-2029)
Figure 75. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share Forecast by Application (2024-2029)
